t-wave [yearbook] 2007

w^nlant ®nibers^itp

3autiolpI) iRata£( iHebical Hihravp

^ i^

Digitized by the Internet Archive

in 2010 with funding from

Lyrasis IVIembers and Sloan Foundation

http://www.archive.org/details/twaveyearbook2007edit

TULANE UNIVERSITY

SCHOOL OF MEDICINE

CLASS OF 2007

T-WAVE

VOLUME XXI

NEW ORLEANS, LOUISIANAmmmmmmmae'.

Tulane Universily

3^

S^i

Sf^eOfh

^

^ ^2

ITulane University

Tulane University Medical CenterSCHOOL OF MEDICINEOffice of Admissions SL671430 Tulane AvenueNew Orleans, Louisiana 70112-2699

(504) 588-5187 Fax: (504) 988-6735

October 30, 2002

Dear Class of 2007,

I take great pleasure in informing you of your appointment to the fixst-year medical class at the

Tulane University School of Medicine, to enter in August of, 2003. 1 sincerely hope that you will

accept our invitation to take your medical training at Tulane and look forward to having youjoin us.

In order to reserve your place in the class, we must receive, within the next two weeks, written

notification ofyour intent to accept our invitation. At anytime between now and May 15, 2003, we

must receive a check, payable to the Tulane Educational Fund, in the amount of $500; this deposit

will be credited against your first tuition billing. Please understand this deposit is non-refundable and

should indicate your final decision to attend Tulane University School of Medicine. We ask that

should you decide not to attend Tulane, you inform us in writing so that we can maintain an accurate

accounting of our class.

I am sure you will understand that your appointment is contingent upon successful completion ofthe

academic program in which you are currently enrolled, and maintenance of the level of academic

performance that was part of the basis for your acceptance. A final transcript ofyour grades must be

forwarded to this office as soon as your school year ends.

You will be receiving additional information concerning summer programs, combined-degree

programs, and other topics of interest as the year progresses. I and others at the medical school will

try to keep you well informed of all important or interesting topics.

On behalf of the students, faculty, and administration at Tulane, I bid you a most enthusiastic

welcome. If I can be of service to you in any way, please feel free to call upon me.

Sincerely yours.

Joseph C. Pisano, Ph.D

Associate Dean

JCP/kj

Tulane University|

3

LP

L

THE OATH OFHIPPOCRATE

I swear by Apollo, the physician^ and Aesculapius, and Health and

All-Heal, and by God and by whatever I hold most sacred? that, ac-

cording to my ability and judgment, I will keep this Oath and this

stipulation—I will look upon those who shall have taught me this

Art even as one ofmy parents. I will share my substance with them,

and I will supply their necessities ifthey be in need. I will regard their

offspring in the same footing as my own brethren, and I will teach

them this Art, if they shall wish to learn it, without fee or covenant.

I will impart a knowleidge of the Art by precept, by lecture and by

every mode of teaching not only to my own children but to the chil-

dren of those who have taught me, and to disciples bound by cove-

nant and oath, according to the Law of Medicine, but to none other.

The regimen I adopt shall be for the benefit of my patients ac-

cording to my ability and Judgment and I will abstain from what-

ever is deleterious and mischievous. I will seek to inform mypatients fully about their illness and prognosis, and will always

remember that the final decision regarding their own life rests

with the patient. I will regard my patients always as fellow hu-

man beings and will do everything possible to preserve their dig-

nity. With purity and with holiness I will pass my life and prac-

tice my Art. Whatsoever things I see or hear concerning the life

of men in my attendance, on the sick or even apart therefrom,

which ought not to be noised abroad, I will keep silence thereon,

counting such things to be sacred secrets. While I continue to

keep this Oath unviolated, may it be granted to me to enjoy life

and the practice of the Art, respected by all men, in all times. But

should I trespass and violate this Oath, may the reverse be my lot.

ITulane University

llv .' 1131

111! (5,

I IK 'i

-.il1'^' .*

1 I I

I i «>, ...

1 - ^!ll! lim llftr

S - II-.

Pfbs?

^:^*«C

Vaf« >**'

K-.®4gB!^^'-''

|'l| Hnn" n n II n n

fel)

\" '#• < Iff '# t

K|r:"r-:^-

::^^i29*!-'

t *

-1«

uianeUNIVERSITYMEDICAL CENTER

Hospital & Clinic !;•% #'S^sijll?*:

Jik

f%

.Kt" r.

^Ai

*MI-4

>• <i3

Tulane University|

5

6I

Tulane University

m^

w*-^^-i

V

NEW ORLEANt sighted as Indian por^.

o Lake Pontchartrain and Gul.:in 1699 by Bienville and Iberville.

p'ounded by Bienville In 1718;

Earned by him In honbr of the

JuRe of Orleans, Regentfpf France. ^Called the Crescent City because of

^location \n bend of the Mississippi. |

II

r

^Szfe'*-*^

-y.

mij??

7r

A\

MTulane University

|/

Tulane University

f^-'^-^;nc.

Tulane University | 9

p ^^^^^^<^9^^^^^^^^^^^^^^^^^^^^H

p^^uH

iP^jwH'ic^r yiPJpBJ^H

rln^a^mSJ».v

^^^^^Tx^Jj^^ fe^^-^F^10

ITulane University

Tulane University|

11

12I

Tulane University

Tulane University|

13

14I

Tulane University

Katrina

Tulane University|

15

16I

Tulane Univefsity

Tulane University|

17

P«^^^H'

'"^'-^rlP'H

¥kki^lmf'4 liil

^^1 Iw^v-^^'^^^^^^Hhv Wf A HP 1

r /1

18I

Tulane University

Tulune University|

19

20I

Tulane University

Cadaver Ball

Tulane University|

21

22I

Tulane University

at Home and

lulane University|23

/^

(^

''jll^^i

24I

Tulane Univer'iity

Tulane University|25

26I

Tulane University

WT —

1

Hi' ^^^^m^^^^^/-"^

, ..^mW A

f ^^H||MHj£^g»<t^^EggM|H|^^H^H|H


28I

Tulane University

30I

Tulane Univer'^ity

Tulane UnivRrsitvI

31

32I

Tulane University

»-J^^H^D^H^^^^^^^^^^^kEiS^^^^r1>#

^**^^>

.

J^WMF ^'T^ 1k^^/Jl

i|Bj|^Hw 1V^ ^^^^^H

w/ \m ^^f ^£mmb— '

34I

Tulone University

Mardi Gra


36I

Tulane Unive'"jity

Mardi Gra


38I

Tulane Univerity

'^.Ji^^j,

-X- « , 1 4

^^n4 .JT^ A i'^'s^il^^ ^>

W^:l^Mni^^^^^^Mf^^- ?l^jEp^T. !

II -^MSi'i n'^*^-

'

!l£^%l fW "^^ '^' iM# 11*- «-^P""*^ T^i1 IS;, wf &

40I

Tulane Univerity

Tulane Universily|

41

42I

Tulane University

s

44I

Tulane Universitv

Tulane University | 45

46I

Tulane Universit"

Tulane llniversitvI47

48I

Tulane University

^^^^^^^^^^^^^H

BIS^^^^^1

H^fert^^^H [^^

V ^ hM^^m k

r^ ^^H ^^H ^^L

^^L

^^mm- nHift^ftj* * <^^^L

/v ^^^1^H^HL^j,

K-'ar-^> ^'^^ il#n^^H.V flB^ >^

• ^^bL '- '^k. .^Mi^mlMr 3^Kl *« / >

. ^Bk^ ^^»™w Jm WKK. ^^:*.^J1m^ ^ mT'*^*^^^

vS^B

' m^-

^^B!»--

y.^-

•SBTK J

50I

Tulane Universi'y

Tulane University|

51

52I

Tulane University

54I

Tulane University

ut and About

56I

Tulane University

^^^^^^^Pl^JM^^H^K-^N^^^^L r?i

ll<

\

1 ^MLki^feK.' "^Sl^^v^^m

aJUOJJUaWjgaU^AJLU-LLMJ


CHAD ABBOTTFamily Medicine

U Washington Affil. Hosp.

Seattle. WA

MICHAELABDULIANOrthopaedic Surgery

Case Western Univ Hosp.

Cleveland, OH

STEPHEN AGANSEmergency Medicine

LSU SOMNew Orleans, LA

ZEENAAL-DUJAILIMedicine - Prelim

Ochsner Clinic Foundation

New Orleans, LADeiTnatology

Tulane University SOMNew Orleans, LA

MATTHEWALLEMANSurgery - Prelim

Univ of North Carolina

Chapel Hill, NC

DUDLEY ATKINSONSurgery - Prelim


New Orleans, LAUrology

LSU/OCHSNERNew Orleans, LA

JEAN AUZENNEPsychiatry

Vanderbilt

Univ Med Ctr

Nashville, TN

APRIL BAILEYRadiology - Diagnostic

U Texas^SW Med Sch

Dallas, TX

JUSTIN BARKERSurgery - Prelim

Univ of Colorado

Denver, CO

JULIA BARNETTSurgery - Prelim

U Washington Affil. Hosp.

Seattle, WA

OSCAR BATLLEMedicine - Prelim

Univ of Missouri

Kansas City, MOOpthalmology

Univ of Missouri

Kansas City, MO

ANDREA BECKInternal Medicine

Tulane Univ SOMNew Orleans, LA

ROBERT BECKInternal Medicine


WILLIAM BECKGeneral Surgery

Vanderbilt Univ Med Ctr

Nashville, TN

CAREN BECKERGeneral Surgery


New Orleans, LA

OREN BERNSTEINAnesthesiology

UCLA Medical Center

Los Angeles, CA

JENNIFER BERUMENGeneral Surgery

UC San Diego Med Center

San Diego, CA

JUNAID BHUTTOInternal Medicine


LAUREN BLEICHInternal Medicine

Lahey Clinic

Burlington, MA

ELIZABETH BORSHARDOtolaryngology

West Virginia Univ SOMMorgantown, WV

DAVID BOWDENInternal Medicine

CA Pacific Med Center

San Francisco, CA

REGINA BOWEMedicine-Pediatrics


ASH BOWENUrology


ASHLEY BROUSSARDMedicine - Prelim

U Texas Med School

Houston. TXAnesthesiology

George Washington UWashington, DC

JEFFREY BURFORDGeneral Surgery

Univ Arkanas

Little Rock, AR

JOHN CAMPAGNAPediatrics

Tripler AMCHonolulu, HI

MARK CAVANAUGHPrelim Surgery

Univ. Michigan

Ann Arbor. MI

HELEN CAVASINOB/GYNU. Arizona Affil. Hosp.

Tucson, AZ

SETH COHENSurgery - Prelim

Lenox Hill Hospital

New York, NYUrology

Lenox Hill Hospital

New York. NY

CRAIG CONARDPediatrics

OSU/Children's Hosp.

Columbus, OH

MANDY CRAUSEMedicine-Prelim


New Orleans, LARadiology- Diagnostic


JASMEEN DARAPediatrics

St. Christopher's Hospital

Philadelphia, PA

BENNETT DAVISFamily Medicine

Camp Pendleton

C. Pendleton, CA

CRAIG DENLINGEROrthopaedic Surgery

Univ Tennessee COMMemphis, TN

KAPILDHINGRAEmergency Medicine

UC Davis Med Center

Sacramento, CA

RENEE DOLLAnesthesiology

Albany Med Center

Albany, NY

MEENAKSHI DUTTAPediatrics


ISSAM EIDOtolaryngology

Univ Texas HSCSan Antonio, TX

GUSTAVO FABREGAAnesthesiology

Univ Arkansas

Little Rock, AR

MIGUEL FABREGAMedicine-Prelim

LSU SOMNew Orleans, LARadiology-Diagnostic

Univ Texas Med School

Houston, TX

ADILFATAKIAOtolaryngology


MICHELLE FERNANDEZEmergency Medicine

NY Hosp/Medical Center

Flushing, NY

JOSHUA FOWLERMedicine-Prelim


AMY FOXMedicine - Prelim

U. N. Carolina Hosp.

Chapel Hill, NCDennatology

U. N. Carolina Hosp.

Chapel Hill, NC

JONATHAN FRIEDMANTransitional

Colorado Health Foundation

Radiology - Diagnostic

U. Texas SW Med School

Dallas, TX

AARON FRITTSInternal Medicine

Temple Univ Hospital

Philadelphia, PA

THOMAS GALLENAnesthesiology

Med. Coll. Of Georgia

Augusta, GA

58I

Tulane University

HUGH GILLSurgen -Prelim

Georgetown Univ

Washington. DCNeurosurgery

Georgetown Univ

Washington, DC

LL\T GOLDMANMedicine - PrehmLSU SOMNew Orleans. LAPhysical Med. & Rehab.

Temple Univ Hosp.

Philadelphia. PA

DALLIS GREENGeneral Surger)'

Naval Med Center

Portsmouth. VA

MORGAN HAILEMedicine - Prelim

Tulane Univ SOMNew Orleans. LARadiology-Diagnostic

Tulane Univ SOMNew Orleans. LA

NATALL^ HANNANSurger\' Post. Doc. Research Fellow.

Tulane SOMNew Orleans, LA

.JEFFREY HARRGeneral Surgery

Univ. of Colorado

Denver, CO

STACY HEIMBURGER-Medicine/Neurology


.JAY HEINTZUrology

Univ Maryland

Baltimore, MD

JENNIFER HEWSONOB/GYNOregon Health & Science

Portland. OR

MARCO HIDALGOSurgery Post. Doc. Research Fellow.

Tulane SOMNew Orleans. LA

VIVIAN IIOANGPrelim MedTulane

New Orleans. LANeurology

Georgetown Univ Hosp.

Washington, DC

ABIGAIL HOFFMANGeneral Surgery

Methodist Hospital

Houston. TX

LARKIN HOLTFamily Practice

Ventura Co. Med. Cent.

Ventura, CA

KRISTINA JOHANSENOB/GYNSAUSHECLackland AFB, TX

KRISTEN JONESSurgery - Prelim

U. Pittsburgh Med Cent.

Pittsburgh, PANeurosurgery

U. Pittsburgh Med Cent.

Pittsburgh. PA

MAYA JONESPediatrics

U. of Southern CALos Angeles, CA

ROBERT JUNGMANInternal Medicine

Boston Univ Med. Cent

Boston, MA

GEETA KARNIKInternal Medicine

Georgetown Univ. Hosp.

Washington, DC

KIRAN KAURInternal Medicine

Univ Texas Med. School

Houston, TX

JOHN KIMTransitional

Emory Univ SOMAtlanta, GAOphthalmology

Emory Univ SOMAtlanta, GA

BRENNAKLOVNINGEmergency Medicine

Maricopa Med. Center

Phoenix, AZ

STEPHANIE KNIGHTPsychiatry

U. of Maryland Med Cent.

Baltimore, MD

SARAH KOENIGFamily Practice

Group Health Coop

Seattle, WA

SPENCER KRANERobotic Urologic Research Fellow.

Henry Ford Med. Cent.

Detroit. MI

MATTHEW LADRAMedicine - Prelim

St. Mary's Med. Cent.

Long Beach, CARadiation Oncology

U. Washington Affil. Hosp.

Seattle. WA

JUSTIN LAFRENIEREInternal Medicine

Naval Med Ctr

Portsmouth, VA

NICOLE LAZARCIUCEmergency Medicine

Hosp. of U. Pennsylvania

Philadelphia, PA

LIFT LEMedicine - Prelim

Tulane Univ SOMNew Orleans, LADermatology


THU-BA LEBAOrthopaedic Surgery

U. Texas Med. Branch

Galveston, TX

CALVIN LEEInternal Medicine

Mass. General Hosp.

Boston, MA

TRAVIS LEEMedicine - Prelim

Tulane Univ. SOMNew Orleans, LAAnesthesiology

Jackson Memorial Hosp

Miami, FL

KRISTINA LEWISMedicine - Primary

Mass. General Hosp.

Boston, MA

DOUGLAS LINCOLNPediatrics

Oregon Health & Science

Portland. OR

MIKE LINDSEYSurgery - Prelim

Univ. Vermont

Burlington. VT

MAUD LIVAOB/GYNUniv Tennessee COMMemphis, TN

STEVEN LUDWINMedicine - Prelim

Thomas Jefferson Univ

Philadelphia, PAPhysical Med. & Rehab


Phildelphia, PA

STEPHANIE MALLIARISGeneral Surgery

Weill Cornell Medical Cent.

New York, NY

DANIEL MANTUANIEmergency Medicine

Alalmeda Co. Med Cent.

Oakland, CA

ERICA MARINPediatrics - Primary

Children's National Med Ctr.

Washington, DC

SARAH MARKLEYPediatrics

Stanford Univ. Progs.

Palo Alto, CA

ALEX MATTHEWSFamily Practice

St. Francis Hospital

Memphis. TN

CHRIS MAYORGAInternal Medicine

U. Chicago Med. Cent.

Chicago, IL

JESSICA MCDONALD-TOPMedicine/Pediatrics

Tulane Univ. SOMNew Orleans, LA

LYNN MODELGeneral Surgery

Yale/New Haven Hosp.

New Haven, CT

AIMEE MONTEROInternal Medicine


DEEPA MOI'ARTYInternal Medicine

Methodist Health System

Dallas, TX


BEN MOSESSurgery - General

SAUSHEC

-

Brooke Army Med. Center

Urology

U. of Texas Health Sciences

San Antonio, TX

ETHAN MOSESTransitional

St. Anthony's Hospital

Oklahoma City, OK

AYE MYINT-UPsychiatry

Brown Univ

Providence. RI

BIBA NIJJAROB/GYNBoston Univ Med Cent.

Boston, MA

CHRIS OBRIENTransitional

U. of Tennessee Grad. SOMKnoxville, TNOphthalmology

LSU/OchsnerNew Orleans, LA

EVE OSTERPediatric - Primary

Mt. Sinai Hospital

New York, NY

LEENA PANDESurgery - Prelim

Mt. Sinai Hospital

Chicago, IL

Radiology-Diagnostic

Cook Co. Stroger Hosp.

Chicago, IL

SZEKIM PANGFamily Practice

St. Francis Hospital

Memphis, TN

MATTHEW PATTERSONMedicine - Prelim

Emory Univ SOMAtlanta, GAAnesthesiology

Emory Univ SOMAtlanta, GA

ROD PELLENBERGPediatrics

Baylor Coll. Of Medicine

Houston, TX

ANTHONY PERRYPathology

St. Joseph's Hospital

Phoenix, AZ

WYNTER PHOENIXGeneral Surgery

U. of Arizona Affil. Hosp.

Tucson, AZ

GAYLE PLETSCHMedicine/Neurology


ULANA POGRIBNAPediatrics

U. Texas Med. Cent

Houston, TX

DAVID POPOLIMedicine-Prelim

Boston Med. Cent.

Boston, MAPhysical Med. & Rehab.

Harvard/Spaulding

Boston, MA

NATHAN POULSONAnesthesiology

Hershey Med. Cent.

Hershey, PA

NEEMA POURTAHERIOithopaedic Surgery

St. Joseph's Reg. MedPaterson, NJ

SARAH PRESENTFamily Medicine

Oregon Health & Science

Poitland, OR

LAUREN RABINOB/GYNU. of Maryland Med. Ctr

Baltimore, MD

ERIK REITEFamily Medicine

USAF Regional Hosp.

EglinAFB,FL

KELLY RENNIESurgery Post. Doc. Research Fellow.


ADAM RIVESOrthopaedic Surgery

Univ of Missouri

Kansas City, MO

TANYA ROGOPediatrics

INOVA/Fairfax Hospital

Falls Church, VA

ROBIN ROLANDEmergency Medicine

Washington Hosp. Center

Washington, DC

ACHAL SAHAIInternal Medicine

Baylor College of Medicine

Houston, TX

GOPI SHAHOtolaryngology


Philadelphia. PA

MARGARET SOULENPediatrics

Wright St. U. Boonshoft SOMDayton, OH

REBECCA STACKHOUSEMedicine-Prelim

Norwalk Hospital

Norwalk, CTRadiology-Diagnostic

Yale/New Haven Hosp.

New Haven, CT

JEFFREY STIMACOrthopaedic Surgery

U. of Louisville SOMLouisville, KY

LUISA TODDEmergency Medicine

U. of Utah Affil Hosp.

Salt Lake City, UT

JENNIFER TORPPediatrics


LANDON TROSTSurgery-Prelim

Mayo Sch. of Grad. Education

Rochester, MNUrology

Mayo Sch. of Grad. Education

Rochester, MN

MICHAEL TUBIANOSAFamily Medicine

Univ. of Hawaii

Mililani, HI

HARMEETH UPPALSurgery - Prelim

Harbor/UCLA Med Center

Torrance, CA

ADAM VAN DEN BOOMPediatrics

Naval Medical Center

Portsmouth, VA

ROSALBA VARGASPediatrics


Houston, TX

SHANNON WAGNERPsychiatry

Northwestem/McGaw

Chicago, IL

JARED WAKEMANPsychiatry

George Washington U.

Washington, DC

KATHRYN WATTSRadiology-Diagnostic

Ochsner Clinic Found.

New Orleans, LA

SACHA JUNIUS WAXOB/GynOchsner Clinic Foundation

New Orleans, LA

MEGAN WESTBROOKPediatrics


Houston, TX

LUKE WILKINSMedicine-Prelim

Case Western Univ. Hosp.

Cleveland, OHRadiology-Diagnostic

Case Western Univ. Hosp.

Cleveland, OH

AARON WILSONPsychiatry

Tulane Univ. SOMNew Orleans, LA

JEFFREY WOLTERSSurgery-Prelim/Urology

Virginia Commonwealth

Richmond, VA

DANIEL WOMACGeneral Surgery

Med. Center S. Carolina

Charleston, SC

AMY YANGInternal Medicine

Brown Univ Med. Res.

Providence, RI

BRIAN YOUNGPediatrics


60 1Tulane University

Zeena Al-Dujaili Dudley Atkinson April Bailey Oscar R. Batlle III Elizabeth Borshard Mandy Crause

Craig Denlinger Issam Eid Jonathan Friedman Aaron Fritts Morgan Haile Jeffrey Harr

Jay Heintz Jennifer Hewson Kristen Jones Douglas Lincoln Mike Lindsey Steph Malliaris

John Kim

Calvin Lee

Dan Mantuani

Erica Marin Sarah Markley Erik Martin Reite Landon Irosl

Tulane University|

61

vrmMiiL^

L. Lee Hamm, M.D.Interim Dean

Mark Kahn, M.D.Associate Dean for Admissions and Student Affairs

Ernest Sneed, M.D.Assistant Dean for Student Affairs

N. Kevin Krane, M.D., FACPVice Dean for Academic Affairs

Barbara Beckman, Ph.D.Assistant Dean for Admissions

Rondel Frank, M.A.Registrar

62I

Tulane University

k iJVBi^HyiP!9 «?-:•-•,. -I^I^W^^^^^.'^^. »*«5a|

Karen Joia Kim Melerine

Melissa Riley Susanna Vargas

Irene Melerine Donald Owens, Ph.D Betty Burton


Tulane University

ciences

Internal Medicine

66I

Tulane University

Psychiatry & Neurology


Tulane University

Tulane University|

69

70I

Tulane University'

A^ . J^>«: ii.Tfiftn

^1?#0.

^j^zM

Tulane University|

71

72I

Tulane Universit"

Tulane University|

73

Oscar BatUeSanto DomingOj

)iiimican Republic

IR^^mB

74I

Tulane University

^am. ^^ni^l

HT L


^^^m * -Jw^^ W^^WliL/^^^wK.'

'

^^^^^1

76I

Tulane University

Tulane University|

77

78I

Tulane University

Tulane University|

79

80I

Tulane Univorsily

Tulane University|

81

82I

Tulane University

Jolin CampagnaDavenportj lA

Tulane University

86I

Tulane University

PIi^^-1i

^^Hg,iJHj-^

1 1 ,^^^^^H||I|1e;'4QS|^B^H

Tulone University|

87

88I

Tulane University

i

Tulane University|

89

90I

Tulane University

Tulane University|

91

92I

Tulane University

Tulone University|93

t^fHfxI 1

Hklf ^^,.H^*,^Tp-'^

\^^^gi^i^^

1 ^^JP3n94

ITulane Utiiver?'ty

jj^^^^^^^^^Hv^^ i l^H

' 1-mI'i.J^^^^Kv. -^^. V^W'^^BBH9|Fvi

^^flj^^ "• M

Tulane University|

95

96I

Tulone Univrrsity

Tulane University|

97

m^MMT^M^fM^^^^ _jW-7W ^^H

^^^K^ ^v ^^^r

•^jfc

i^^^r^^ ^ii|H|

A\mi P ^wr _

mmmm ^'f i^^l

98I

Tulane University

Tulane University|

99

100 1 Tulane University

Tulane University1101

1wBS^^^'

1


B^K^'3|^1 u\ v^ f

wy1 w^

I


1061 Tulane University

/.« ><

lllM ' mf -^^^^K A^^Hflw^^^HM

^/iMlnTNS^H"" " ^' m

'A108 1 Tulane University

Pittsburgli


110I

Tulane University

^"^sn

112I

Tulane University

114I

Tulane University

Tulune University|115

^g^^^

116I

Tulane Univprsity

118I

Tulane Univfirsity

^^HJB|^p^f! fit•mmmi^^^m- ^^^^^^^B''^^imHHi^rzk ^^M

;i


124I

Tulane University

I

^^^H ^^^Bkv^ '-^'* "^ --.'-Afc'xAjJ

^^^^^H^^^ ^Hr\-:i:>^-r^^l^^^^^^^^^s ^^^Km->^- :'i- ^^^^1

wmz' '

K-jJl^^j[ "~ °^^^i^^^^B Wk -^^uM^BIim 'JH

H u126 1 Tulane University

'S'J^^'^TS'm"~^ ^y '

128I

Tulane University

Tulane University |129

130I

Tulane UnWersity

Tulone University1135

^BÎ^^B^Î 1 "'^' rVv^l ^^^^^1WS^^^^^M ^^^•M" i^fP^Î^^H^H

H^^l ^^H^^^^p ^^^

,,

.

ji "1^ ^^^Vyv;

^^^^^^kk HH^^


^^E H^^

'

B~X'':* tf '^D

w/IP / 9'

Hk^^^^H U_^^- .^^

¥'.' "^^^^^^1I^^^Su.

T^/ ^-i^.f^^^1^^^138 1 Tulane University

IJWV^^^^B

^cfl

^^p fH^^^^^^^^^^^^^^^^^^^Î

r i,^îH^pm

L

V^^^^l

^^/- i/vHBÎ

^k ^ iwH


140 1 Tulane Univ"rsity

New Orleans...there's no place I would've rather done it!

Jay- What can I say brother...4 years of friendship much appreciated. Congratulations on AOA, UMD-urology (keep your eye on

the...), and meeting your lovely wife. You did well during these four years! Never forget though, no matter what, I'll always be taller (I

don't care what your driver's license says), younger (by a year), and while we're at it more handsome. You owe me $50 for Bonds...I'll

take It out of the wedding gift. I will see you and Eva soon. Megalo- You'll always be very special to me. I wish you the best in all

your pursuits and know you will find happiness. ..Your kind-heartedness (which is only rivaled by your lack of knowledge of the world-

What language do we speak in India? In fact, where is India?) assures you of it. Also, you're a hippie, I think you look good in earrings,

and it's about time you bought a big purse. I love you very much. Kev- Who's the biggest guy in the med school? Pound for pound you

know the truth, I missed you third year, but I guess if you were around all we would've done is drink protein shakes, eat Roly Poly, and

talk about your girl troubles. Thanks for everything man. AY, AY- I'm glad we were able to spend these last four years building on

what has to my delight turned into a lifelong friendship. I'm sorry about the Chinese food, but I wonder ''are you not entertained?" Oh

and "guys if I wasn't, like, her sister I would totally..." Ap- Lab partners to great friends. It's like destiny. Houston was the best,

once you got rid of that ball and chain. Who else can I daydream about being filthy rich with while lying in the sun, poolside. "So away

from my window..." And don't worry, I was only joking when I said getting dogs cuts your dating pool in half. See you somewhere in the

sun. My girls+l...I couldn't have asked for better roommates. Jess- I think you are one of the sweetest and kindest souls I have ever

met, who can also cook with the best of them. Please try to hold your vodka down and keep the dogs in the front of the house like you

promised! Nate- You're not in school with us, but how can I leave you out. You want to walk up the off ramp to meet Jess in the

middle of the highway? I don't get it, smoke dawg. I know that you and Jess are going to be great together and I look forward to

visiting you guys over the years. Kothryn- "I don't know what it is, but I want it." I love listening to you speak. I'm so glad that you

came back to us. Cool to chill out with, cool to go out with, and cool to spend New Year's with. You've got it all. Morco- We had great

times V year, .then you got married, had a kid, moved to Metairie all in the blink of an eye and I never sow you again. Just joking, I

look forward to always keeping in touch and I wish yourself, Barrie, and Riley (the cutest kid I know) all the happiness in the world.

You'll be good in whatever you chose to do. And Bam'e- Thanks for your friendship. You'll always be a southern belle with social

standing in my eyes. Art- It was good to know you buddy. Wake boarding, Centreville, making you cry on the golf course, tennis court,

and racket-ball court. I enjoyed it all. If anybody did medical school the right way, it was you. FPlttS- One of my favorite memories

remains playing pool, eating a cheeseburger, and having a beer at Igor's. You're a great person, which is maybe why you're so terrible at

talking trash. I'm always there for you. Sopi...come on be honest-who talks more? I wish you guys the best of luck together. MJ-Who's got a chip on their shoulder? Thanks for taking care of me when I was sick 1^^ year and for everything since! It's too bad you

moved to the AAarigny...You like my jokes, come on! Roddy- I'll never bet with you again, but I love you never the less. My mom is still

worried that you're going into pediatrics. I know you'll do great though. So Hoyas! Nicole- Your charm is in your cynicism...but don't

forget that you're destiny is a happy one. Thanks for picking me up on St. Charles at 6am. Zeena- You're not high maintenance. I

loved all the time we spent together V^ year and you get a standing happy birthday from me on Feb 23'"'^ of every year.

Lauren/Liat/Seeta- I only lump you guys together b/c you're such good friends, yet I had separate friendships with each of you

and appreciated each one of them. Thanks. Pinner- Hey man, you made my third year of medical school easy. Lab A2

Craig, Amy, Aimee,Ap,RJ- Let's just start by asking which lab group was the best in our class? You guys were the beginning of a

great experience. Others, all of whom I thank for your friendship-AB,AH,AS,BB,BM,BN,BY,CBx2,CD,CJ,DB,D&,CiM,FaD0,DW,HU,IG,

JBx4,JC,JD,JF,JG,JWx2,DrJW,KJ,KK,LM,LP,MD,MA,MC,ML,NG,NM,NN,NP,OB,RB,RK,RR,SB,SC,SK,SL,SM,SY,SW,TB,TG,TI,TR,WP.

Dad, Mom, Anuj, Rohan, as well as family and friends from further away- im where i am today

because of all your help. Thank you!


11

^fkm


148 1 Tulane Univ:^rsity

^^ <-"

-„

^

|gggTulane University

1149

Michael TubianosaFarmiiigtoiii, CT

ri^kr'!BM

@hI ^Xv*^^!

^^^mTW^^^t^ m9 '^iT^SV^^v ^H

^Qv^^PW Iho150 1 Tulane University

152 1 Tulane Uni'/ersity

^w

1

^^W^ ; R^ ^

r ,\

htlV


Tulane Universily1157

Tulune University1159

Stephen Agans Jean AuzenneOpelousas, LA

April Bailey

Wenatchee, WAJulia Barnett

Houston, TXWilliam Beck

Stayton, ORJohn Bernard

Boston, MA

Oren Bernstein

Oahu, HILuisa Berry

Boulder, CODavid BowdenDecatur, GA

Ash Bowen Arthur Caire

Slidell, LACraig Conard

Bennett Davis Kapil Dhingra Renee Doll

Orange Park, FL MiUington, NJ

Meenakshi Dutta

Palo Alto, CAAdil Fatakia Joshua Fowler

Gladstone, OR

Jonathan Friedman

Franklin, LADallis Green

Fayatte, MSRobert Jungman

Kuston, LAKiran Kaur

Houston, TXJohn Kim

Pearl City, Hi

Brenna Klovning

Charlottesville, VA

Scott Bourgeois Natalia I lannan

New Orleans, LA


j^i

Spencer Krane

Metairie, LAMatthew Ladra Nicole Lazarciuc

Toronto, Ontario

Liet Le Thu-Ba Leba Calvin Lee

Houston, TX

Kristina Lewis Steven Ludwin Daniel Mantuani Erica Marin

Chapel Hill, NC Randolph, NJ Rochester, MI

"^^pr^^

Alexander Matthews Ethan MosesDenver, CO

Aiidrea Montis Beck Aye Myint-U

New York, NY

^vt^Bi

QiiTstopher O'Brien Szekim Pang Anthony Perry Gayle Pletsch

Baton Rouge, LA

Erik Reite

Denver, COMargaret Soulen

Colombus, OHLuke Wilkins Aaron Wilson Daniel Womac Brian Youiig

Adrian, MI New Orleans, LA San Antonio, TX


Stacy Heimburger Jennifer Hewson Douglas Lincoln

Stephanie Malliaris Jennifer Torp Shannon Wagner


mf Ip ^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^

Hâre scy 3/'c>ii

Or (Xtr o-i(f SLs£cr

/"

Siaa/ /iei/nmri/e/} /"i/L./j.

CMJra£u£t£i(M^f

L(H^c BecKi/ (Kb 7^v

1l fI

U4i!t -m.erdy lAAiybtiievaJjie. .

.

ut'i far IreyonA aAdiXizuta-

iA:\ jiut cLoTAmrlakt. .

.

iKx^rKceivoMe

ConaraUdcdimvi Dr. HedMJruraer,

wt are p<? i^try fôud ofyou.

We CoT/eyou.

Unxie, At4Mt Kcnui, MaMsoK,y(n4r

joddAu^vterJacky omA Arthur

XOXO i

^^5^^^^^5^?5^^5^^^^^^^^^^^^^^^^^^^^^^^^^^«^^^^

Conîatuiationi on, tôut îadtiation ^m. ûiuuii SchooU

LUi. uui/igou. aJl tfu. biîit 06 tiou, iLoch t/u, nuu-ôaLb aou. tetôt

gouztd^ and idte. the, taUntii that Qodâue,gou, to htlp ot/uii

.

UJt. aii, io fiioud o^tôu./

Couf,, âd,, 9^7001, and Ûan,

(^reatworh, Stephyl

Wey owe^ Kf- IncredMyiyproud/ ofyaw!

Lovey, Moo-, Ted/, OAnd/lvy

164| Tulane Univtrsity

Con/jrahdcutumA to ovw um Seth omA to tke cUm of2007

We wUk you all ike htst oMd for a, s44Axe9sfid cmA rmmrdum

ccure^tr i4t -medkMie. May tke itadcy of TutLute Medlad Sckaoi

cofvti4iAU to Lwt OK.

Frmt tke Coivefi FoMuhj: EUetK, EiLuft) ^eik omA VUia


landijClLL

We Me so p\oud of l/oli and we love you

witli all of out hearts'.

mom, ibad, ^skleu, Jiati, and J)ee

You /yiOi/ GinC-tDi^tit&r- /yieaj^ d^-fâts^ ût you /yju^t fiot £>&

de/sai^J. Xjo -fad, it /yios/ ie. ne-C^SSai-y to £nC-oatit^r

t/is de-feats, So you doj^ /(nouj uj/io you are, c^hat you

<ia^ t'iSe -fi-o/t^, Jioto you dori StU/ c.o/yi& o^ of it.

-Maya Atiae-Iou

Dear Stephanie Rose,

You have encountered more in the past four years than many see in a

Ufetime, and you have not been defeated. You have risen from your

experiences in New Orleans and, through it all, you know who you

are more than ever before. We have always been and continue to be

your proud and loving parents. You are a phenomenal woman!

XOXO, Mom and Dad

A ^

Congratulations

morgan ana Jennl

We ale so incieatbiLj

ploaa oj yoal

Witk all oj oul love,

J-ôm goal entile J4ailejamdg

The/ early carving of a/future/

hrcuyW HArê^yn/.

Conâtulcutuyn/y ViMviphin/,

we/'re/ yo-proud/ ofyou/!

Love/,

Monvand/Johrx/

166| Tulane Univirsity

Michael,

Uove of m.y life, oucrjoutriA/ey together startecH wheiA. we

were ±S years old. (ia, the last decade we have growiA.

together aiA/d achieved oucr dreai/vts haiA/d aiA.d haiA/d. i

will always be your # i. faiA/ aiA/d will su.pporfc y out Iia/

aiA.y eiA^deavor youc u.iA/dertal^e. ThaiA.teyoi/tfbrlettliA/g

n/te walle this jou.riA.ey fucll ofjoy aiA/d laucghter with

you.. I am. so 'prou.d aiA/d hoiA/ored to have you. as m.y

hu.sbaiA/d. CoiA/gratu.latloiA/s!

You.r best frleiA^d aiA/d wife

L-ove always,

3ylvla


ConîaUdatwnJi to nui in£i£dihk. dau^htei,, êehi.l

(]amiio pioudoâou,. WhiJi.!iowuui£./a!ita,littU.QiiidtEa/nin^

0^ luhat liou. rruui tomedaii bicomi,, ^ knuu- now would find

liouiidjj hilpin^ ot/uii . lôu, haue- atuuuit bun. io aaiins and

oompaMiijonati., <u)upUdutilJidiiui,cuiddUtiJninjatwn.. LôiLhaui,

ajC£omf)li!>kuL luhat ii attainable, ba only a, êw-. <7 uulL nufii.

jjoiît hoiu. ^fulpedgou. kain. hoiu- to lual/c. and tktn. gou,hdptd

mi. utalk, aâui. LJou, aze,ma biight and thinJny !>tai,l

fllLnm bui,,

ôm.

/o^ iha/'^ aVi^l-Cô/yê. aj/ /('it^dS of oAstaCi/e.3 ujith

youI- usuaj style, and QtaCe. lê. icôuj you cui//

iê ari e><(Ze-//&tit physic-icxn., ancl are. vet-yptoud a-f

yoa . ijooJ ludk) 2)/-- Pande!

LoVe, Petty, Mo/y?, aid 3>ad

CoMtai^/al'ioriS Js/^nl-f&t arid Mor-QOM. A//

yoc^t /lard ujot^ /las ce.ttai/i/y pojJ o-f-f.

You uj'i/I ii>ot/i Ae coojnd&i-fu/ /?h/3idia/i3

/^&Ciau3& you are. Aoth iAjotide-tfu/^&op/e.

.

iOe.ite Very proud o-f you

.

A// out /oVe. Mo/y?, 2>acl and Brian.


Dearjejf,

We feel such pride and happiness for you. You kept smiling, believing in yourself and following that third grade dream of

becoming a doctor You are there! CONGRATULATIONS

We love you.

Mom and Dad

Seize the Moment

Seize the moment before its gone Ifor another day begins at dawn. I Embrace the )iight winch brings you rest I awake and know

you did your best. /Fight each fight and run each race-it matters not ifyou win or place. I Seize the moment you'll be blest

I then rest assured you passed the test, Ifor he who tries can never fail I when God directs the ship lue sail. I Seize the moment

and hold it dear / and rise by faith above yourfear

Dearest Beckv,

I'm 50 very proud of you and all you've accomplished! I'd be

remiss if 1 didn't take credit for a little moral support here

and there, but you're the one who did the studying, endured

ail the crappy residences and spent endless nights on call. Thetime I've spent with you has been the best three years of mylife. 1 can't wait to start the rest of our life, finally and really.

together, forever.

Congratulations, I love you with all my heart,

Don ^^^^^^^^^^^^^^^^

p^'-f wHT^^^^^l

^^pcnccr — \/i^UA ^rcdt -^riAe dnd X/DVi/


iJlllllllllllllllllllllllllllllllllllllllllllllllllllllllllllllllllllb

"You've come a fona way, 6a6xjl We're

ver\jj)roudoj ifou, Jessical"

Love, ivlom ancf'Kim

/" =

S€>A^^'^^^' \

-riiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiir

'^ec/h'MU/.

^'0/:/iM. ti/ne. Sfa//> /'c/n//tc/ec/o/'l/iccfa/'ia//o//o/^///eAocm,

":y'ootsie/M'' ut/iere al tt/n.&s t/ia'e (ucrc cAaateo .s.te/>S' ana-

io/w/t c/ti£siianecl, ffod resAoru/ed (Aat (Aose a/e/'e fu/ies

iv/ien (oe^ c/anced.' ^lis-is a/ie o/'lAo<se Cime-s. c/i ac/di/:io/i to

^t/-i£ /4. l^S'O. y/oti /laae mac/c /ne />rouc///luou/' a/.///el-

ios, mime, acac/e/n/cs a/7z//'n eoc/y c/qy ///c' '2/ou tve/'e lAc/t.

nacv' anc/III///a/wrn/J!- 6e nw. /ia6u..

0ad

170| Tulane University

Congratulations to Dr.

Stacy Heimburger, my smart,

Deautiful and talented

daughter- a 2poo ana Icind

sister who overcame manu

obstacles to achieve this

reat success.

Love Mom, Aaam, and Kommel.

Co/iataici/cjiiiofiSi coe aye proud o-p you :

IaJ/net-&/e.t yout jPaîh /^lay /ea<J, e/voy li-fe,

e><p/o)-e. and Jo your ouj^ t/iiâ.

l<)& /oVs. you, 2>r. Pi~eS£*it!

Mo^ and êeJ

Adaw (The Trophy Husband)

You have made we so proud.

From the moment that I met

you, I knew that my life would

never be the same. The courage

and endurance that you showed

during this journey is inspiring.

You are a strong, beautiful

loving, and brilliant man; and I

have never been happier to call

someone my own.

All of My Love,

Marylyn (The Pabe)

Tulane University 171

FyôÂA, the vem begLiA.iA,LiA,0 there

was, a dreci^vt

Yesterday is already a dream, and tomorrow is only a vision; but today,

well-lived, makes every yesterday a dream of happiness, and every

tomorrow a vision ofhope.

-from the Sanskrit

Congratulations Kelly!! Love, Mom, Dad, Uam, Scott & Rachael

Coi^gratu.LntioiA,£ Dr. Chad Abbott'.

I am. io ffou-d of you. aiMi uour m,cit\.M ciccokM,pUskim,ei«-t£ Iia, Life.

c^radnatlvK-Q from. Tulavê hAtdlcal SolnooL Ls a big oiM'.

As n teeiA-dger, you. showed n grewt Love forpeopLe ai^d heLpLi^g

others. I was, thrlLLed wheiA- mdk. voLu.n,teerecl with m.e, coacM-

L^vg the s-peciciL oLMMA-pLts Trcicte team,. An.d, wu hoiA-ed youtr

dain,cl\^Q slelLLs at the AdnptLve VroQi-am, dcnA-tes. t+ow does the

'"RM-vî/îi/^Q MciiA.' go aQaivLl

Yon wi-LL hcix/e m,fiw,y i/nore Life eAperi.eiA,ces thcit l hope you. ltar\r^

from. niA,d treasure. I feiA-ow Losi.iA,g your father was tough, but

youfoLLowed uou.r drtam^to cittei^d m,edlcciLschooL. your father

wouLd have laeeiA- very proud ofiAou. tte's teeepi-i^-g ciia, eye oia, you

frokw. dloove.

you teki-ow I wLLL be there for wu everu step of the way.

Lovi/tgLy, your step-«<.om.,

Lisa Kadowatei

YoiA/ are/ going^ to- he^ cvyv e^ccepttoncib

doctor hecau4,e/ ofyour convpcMMyOn/,

inteUlg^yncey, oYidy ev\thuH<Mnv! Yowcdwayy gê^ your heart cvnd/ youh. We/

love/you/ cmd/ are/ yy- very proud/ ofyow!Way to go-, Vr. Wagner I

Love/,

Mama/, Vaddy, Anvuv, Verek/, Keith/, and/Morgarv


Jennifer,

Even as young as seven you had dreams. Through

your perseverance, hard work, gentle personality and

intelligence, you have earnedyour own cap...and a white

coat to go along with it We are so very proud ofyou. We

wish you happiness and we know you will be a competent

andcaringphysician. Tourpatients will loveyou almost as

much as we do.

Love,

Mom andDad

Team Family Practice

L-lfe Is R series, o-f begliAîA^LiA-gs. Y^^^grfldu-fltloiA. frowL the Tulavê s>c.V\ool o-f

MedlcliAê Is iA.0 exceptloiA,. you. begliA,

fliA/Other phase of \AD\A.r Life, ci Life -filled

with prlvlLeges society ooiA/fers to oia^Lu

the very best, oia.Lm to those who have

eariAêd. thei^. ALoiA^g with the privileges

co\ês a great bu-rdeiA, of respoiA^slblLlty.

We feiAôw Mouc wlLL serve Mou.rpatleiA.ts

to the best of ujour ability; they wlLL

be fortu.iA.ate to have you. as their

physlclaiA.. we wlLL always be there to

su.pport Mou. liA, aiA,y way we c-aiA..

U)ve,

i>ad a\A.d iaov\a^


^^'si'^Jvw--'^*''*^' '

Jenica.,

I've 'nen/tr htut -vMxre fmid cfyim. thMt I oml today. Ynt

koA/t cicc&iAwU^keA mAAyck bivtymr Ire^t dam are yelr to

c&me. Take tmu to itoP omA um.M the ras^ aJxnw tke umy

(arUmMy). FaMuiy k vtry iMAMrtoMt to you and kjtyw

thai IwM always Ik there -for you. That's what duds are

for! I wi/sh. you a/s i^uickjoy 04 you haxn aU/en -me. ifyou

evtr aeir tired of praxiicUia mzdiclne, I Imow -where you

and I coK aet a. areat fiafter route. Lei- -mi leoA/e you with

one Piece of adidce that I'm. sure they -Kever unrered in

nted sckffol - viervtr fut salt ok a -wound.

CoKaratuiatiom!

Dad

Wecommend you

for your „ ,

accomplishments

and wish you

continued

success.

Anaheim MemorialMedical Center

Congratulations, Tulane University

Medical Sctiool Graduates!

For over 25 years, Bryan Corporation has

been devoted to providing health care

professionals W\\h unique, high quality

nnedical devices and innovative

pharnnaceuticals.

We look forward to working with you

in the future!

For more information, call 1 -800-343-771 1 or visit our website at www.bryancorp.com

BRYANCORPORATION


Benchmark Brands

Congratulates the

Tulane Class of 2007

uFootSmartSMARTER, BETTER PRODUCTS FOR LOWER BODY HEALTH

Benchmark Brands is the leading

U.S. direct response marketer of foot

and lower body health products.

Visit us at www.footsmart.com

C H A F F E M c C A L L

We apply enduring principles in

changing times

Broad knowledge. Deep understanding.

Effective representation

Managed Health Care Tax Law Hospital Liability Litigation

Antitrust Health Care Contracting General Litigation

Labor and Employment Law Medical Malpractice Law

New Orleans * Baton Rouge * Houstonwww.chaffe.com

Congratulations

Tulane Class of 2007!

We wish you the best!

•VeCisco is proudto Have servedthe

dermatoCogic communityfor o-ver 25 years

6y offering innovative products,

superior customer sendee and

a comprenfiensive new practice

start-up program.

uEst. rgSo

DELASCO

VISIT US AT WWW.OhLASCO.COM

At First Bank and Trust we understand

the importance of investing in the future. Wecongratulate you on investing in your

future as v/ell.

As a Financial institution invested in community vitality, First Bank and Trust

is ready to cultivate a strong partnership with you, servicing your

private banking and investment needs by grovs'ing your business, building

dream equity, and delivering service that is alv/ays personal. Congratulations

(o the gradijaling class of Tulane University Medical Center.

ik'.FIRST BANK

AND TRUST i

Business. Mado Personal. =

Oiiu lAi IJANKiNt; Pauimu oi nil NiAv Oui.iiANs Saints

POYDRAS 584.5900 METAIRIE RD. 586.2720 ALGIERS 586.2640 ELMWOOD 586.2700

KENNER 586.2600 MANHATTAN 586.2620 BATON ROUGE 225,925.3014


con^ratpitatlons, to tki

Forest Pharmaceuticals, Inc.Pharmaceuticals • Therapeutics • Healthcare • Ethicare • Managed Care • Specialty Sales

to the Tulane Class of 2007

Hitachi Medical Systems America recognizes the

important contributions made by Tulane graduates to

the advancement of health care and wishes you

the best of luck in furthering this

commitment to excellence.

HITACHIHITACHI MEDICAL SYSTEMS AMERICA. I

Slidell Memorial Hospital has the latest technology, a thriving com-

munity, and a staff dedicated to providing the best healthcare. Our

recent technology investments include a 64-slice CT scanner, an

Image-Guided Radiation Therapy (IGRT) system, three 4D ultrasound

systems, and digital mammography. ..v/ith more new equipment on

the way! Slidell is rapidly growing and so is our community hospital.

We can assist physicians in building an independent practice or join-

ing an established group. Come visit us and find out what

Slidell Memorial Hospital has to offer you.

Slidell Memorial Hospital

Your Hospitalfor Life!

PLEASE CONTACT PHYSICIAN SERVICES AT 985.649.8509


stryker'

Instruments

-^

Class of 2007

We Salute You

Congratulations

Graduates

Class of 2007r^W'^

Pamlab, LLC4-oC*MlMO)tAWNEM*L£ATE 7 Ij L'^ f \/

deplift^

f 4wiCUiaiM>UHINEMAL£ATE

Met^

• Panlor SS

CerefolinNAC l MGTHVLPOLFITer .

Graduating Class of 2007

Tulane University Medical School

CONGRATULATIONSon all you have accomplished and

all you hope to achieve in the future.

Watson® SM

SM


Congratulations Class of 2007

Tulane University Medical School Graduates

For over 20 years Alliance Imaging has provided turnkey solutions to hospitals and

other health providers for MRI, PET, PET/CT, CT and Radiation Oncology. Alliance

partners with hospitals and healthcare providers for Diagnostic Imaging Centers,

Shared Mobile Services, and Cancer Services with a focus on Radiation Therapy.

We look forward to working with you in the future!

/^F\

^ •_ i,"^ ' -«.

(^ AllianceImagingwww.allianceimaging.com 800.362.5816

4020 McEwen Rd, Ste 152. Dallas. TX 75244 Contact: Robert Hardy

When it comes to your career, you want to be part of an

experienced health care team that is driven to provide top

quality care. Forrest General and its staff strive to provide

the best possible care— from medical emergencies to

spinal or open-heart surgeries, from delivering babies to

managing diabetes or other chronic illnesses.

Forrest General Hospital is also home to the region's only

Level II Trauma Center— offering the highest level of

trauma care available in the area. If you're looking for a

place to make your home, join Forrest General. Working

together, we can achieve great things!

|)ForrestGeneralHOSPITAL

Call FGH OnCall at 7-800-844-4445 to find out more about Forrest General

and the opportunities available to you, or visit forrestgeneral.com.

Congratulations graduates

from your friends at

HEALTHPOINT ®

Advancing medicine thru products in

woundcare, dermatology and surgery.

HEALTBPOIBITA DFB COMPANY

®


Coventry Health Care Congratulates

the Tulane University Medical School

Class of2007!

TCOVE N TRYHealth Care of Louisiana. Inc.

Group and Individual Health Insurance Plans

Designed to Meet YOUR needs.

^ Direct access plan designs (specialist referrals not

required.)

Prescription Drug Coverage.

Preventative vision benefits & hardware discounts.

Dependent out-of-area coverage.

Emergency and urgent care coverage titroughout

the United States and Puerto Rico.

"^ WellBeing health and Wellness programs.

Y Excellent Customer Service,

For more information, visit us at CHCLA.COM.

Life has its moments.

Graduation is one you'll

remember forever.

Congratulations to

the Tulane University

Medical Center's

Class of 2007.

^ MARSH FIELD CI, I NIC,

CONGRATULATIONS

\\c take our licit of]

to the oniaiiatniii class

of liilanc L nivcrsity

1KlcJical Center.

And we welcome you

as a trusted partner

in providing quality

patient care.

^ ALLERCAIMINNOVATION AT WORK

©2001 Allcrgan, Inc., Ininc, (]A 92(112

\\'\v\\'.,illci;2an.coiii


Congratulations, Graduates

!

From Kindred HospitalNeiu Orleans

Kindred Hospital New Orleans is a long-term acute care hospital,

offering a full range of services for patients whose medically complex

conditions require the specialized care and prolonged recovery time

that conventional short-term acute care hospitals are not equipped to

provide. We are proud citizens ofNew Orleans and we congratulate

this year's graduates ofTulane University Medical School.

KindredTHospitalNew Orleans

3601 Coliseum Street

New Orleans, Louisiana 701 15

504.899.1555

504.894.7679 fax

www.kindredhospitalnola.com

Because it's always someone's

loved one on the table.

1

—

'

\%Every time a surgeon enters the operating theater,

a precious life is at hand. To ensure that the

instruments are ready when the surgical team is

ready to operate, healthcare facilities turn to IMS.

The IMS Milestone® process maximizes instrument

performance through:

• Education

• Proactive Maintenance*

• Trend analysis

• Process Improvement

• Surgical On-Site Support and Coaching

• Department Management

^^^^lLi>aVisit imsred.com or call 1 .800.783.9251 WimtfiMrfK

r ^

CONGRATULATIONS!Tulane University Medical School

Graduating Class of 2007

with 160 years of dedication to the advancement of

dermatology worldwide, Stiefel Laboratories, Inc. is proud

to join in the celebration of your success andfuture achievements!

Yesterday, Today, and Tomorrow

Stiefel Laboratories, Inc. Coral Gables, FL 33134 1 -888-STIEFEL (784-3335) www.stiefel.com

©2007, Stiefel Laboratories, Inc. All rights reserved- STI-18-2007-USA s STIEFEL

J180 1 Tulane University

CONGRATULATIONSTo the graduates ofTulane University

School ofMedicine

^

It is our privilege to help you

Redefine Recovery" with

significantly better post-op pain relief.

OnQpPainBuster'Redefining Recovery^

www.itio.com

interna ZentarisCommitted To Cure

We wishi to congratulate the

2007 graduating class of

Tulane University

Scinooi of IVledicine

/Eterna Zentaris is a specialist-driven biopiiarmaceuticai

company focused on endocrine thierapy and oncology.

www.aeternazentaris.com

Congratulations to the

Tulane Class of 2007Dedication to the highest standards of achievement helped

you reach your goals. At Karl Storz Endoscopy, we've

embraced that same ideal for more than 60 years.

Endoscopy is all we do. Our products prove advanced

design, precision craftmanship, and clinical effectiveness

will outlast shortsighted trends.

Quality is not disposable. Call us at (800) 421-0837.

STORZKarl Storz Endoscopy


As an adjunct to diet

CRESTOR is indicated as an adjunct to diet to reduce elevated levels of total-C,

LDL-C, ApoB, non-HDL-C, and TG, and to Increase HDL-C in patients with

primary hypercholesterolennia (heterozygous familial and nonfamilial) andmixed dyslipidemia

CRESTOR is contraindicated In patients with a known hypersensitivity to

any component of this product, in patients with active liver disease or

with unexplained persistent elevations of serum transaminases, In

women who are or may become pregnant, and in nursing mothers

It is recommended that liver function tests be performed before and at

12 weeks following both the initiation of therapy and any elevation of dose,

and periodically (eg, semiannually) thereafter. Should an Increase in ALT or

AST of >3 times ULN persist, reduction of dose or withdrawal of CRESTORIs recommended

The effect of CRESTOR on cardiovascular morbidity and mortality has notbeen determined; long-term outcome studies are currently underway

Please see Brief Summary of full Prescribing Information

on reverse side of this advertisement.

Please visit our Web site at www.crestor.com

• Rare cases of rhabdomyolysis with acute renal failure secondary to

myoglobinuria have been reported with CRESTOR and with other drugs In

this class. Patients should be advised to promptly report unexplainedmuscle pain, tenderness, or weakness, particularly if accompanied bymalaise or fever. Therapy with CRESTOR should be discontinued If markedlyelevated CK levels occur or myopathy Is diagnosed or suspected

• CRESTOR 40 mg is reserved only for those patients not achieving LDL-Cgoal at 20 mg. Patients initiating statin therapy or switching from anotherstatin should begin treatment with CRESTOR at the appropriate

starting dose

• Adverse reactions were usually mild and transient; the most frequent

adverse events thought to be related to CRESTOR were myalgia (3.3%),constipation (1.4%), asthenia (1.3%), abdominal pain (1.3%), andnausea (1.3%)'^

HELPS GET CHOLESTEROL RIGHT

loe CRESTOirrosuvastatin calcium

AstraZeneca^

182| Tulone University

BRIEF SUNWAARY: For lull Prescribing Inlormalion, see package insert.

INDICATIONS AND USAGE CRESTOR is mdicaleti: i. as an adjunct lo diet la

reduce eêvaled latal-C, LDL-C. Apo8. nonHDL-C. and TG levels and to increase HDL-C in

patients ftith prmary hyperctiolesleralemia [heterozygous familial and nonramilial) and

mixed dy^lipidemia (Frednckson Type lla and lib); 2. as an adjunct to diet for Ihe treatment

of patienis ft-ith elevated serum TG levels (Fredrickson Type IV): 3. to reduce LDL-C, lotal-C,

and ApoB jn patienis vviih tiomozygous lamilial hypercholesterolemia as an adjunct lo olher

lipid-lowering treatments (e.g., LDL aphersis} or if such treatments are unavailable

CONniAINDICAnONS CRESTOR is contraindicated m palients witfi a known hyper-

sensitivity to any component ot this product Rosuvastatin is contraindicated in palients

with active liver disease or with unexplained persistent elevallons of serum transaminases

(see WARNINGS. Lver Enzymes). Pregnancy and Lactation Alherosclerosis is a

dironic process and discontinuation ol iipid-lowenng dnigs during pregnancy should have

Bttle impact on Ihe outcome ol long-term therapy of primary hypercholesterolemia

Cholesterol and other producls of cholesterol biosynthesis are essenlial components for

fetal development (including synthesis ol sleroids and cell membranes). Since HMG-CoA

raiuclase inhibitors decrease choleslerol synthesis and possibly the synthesis ot other

biologically active substances derived from cholesterol, they may cause fetal harm when

^ministered lo pregnant women. Tfieretore, HMG-CoA reductase inhibitors are coniramdi-

cared during pregnancy and in nursing mothers. ROSUVASTATIN SHOULD BE ADMINIS-

TERED TO WOMEN OF CHILDBEARING AGE ONLY WHEN SUCH PATIENTS ARE HIGHLY

UNLIKaVTO CONCEIVE AND HAVE BEEN INFORMED OFTHE POTENTIAL HAZARDS, Itihe

palKnt becomes pregnant while taking Ihis drug, therapy should be discontmued immedi-

ately and Ihe patient appnsed oi the potential hazard to the lelus WARNINGS liver

Enzymes HMG-CoA reductase inhibitors, like some other lipid-lowering therapies, have

been associated with biochemical abnormalities of liver function The incidence qI persis-

tent elevations (>3 times Ihe upper limit ( normal [ULN] occurring on 2 or more consec-

utive occasions) in serum Iransaminases in lined dose studies was i. 0. 0, and 0.1 % in

patients wbo received rosuvastatin 5, 10, 20, and 40 mg, respecliveiy. In most cases, Ihe

elevations were transient and resolved or improved on continued therapy or after a brief

interruption in therapy Tiiere were two cases of jaundice, for which a relationship to rosuva-

sHIin Iherapy could not be determined, which resolved after discontinuation ol therapy

There were m cases ol \m lailure or irreversible liver disease in these tnals. H is recom-

mended hat liver function tests be performed before and at 12 weeks tollowing bo^ (tie

mitiab'on of therapy and any elevation ol dose, and periodically (e.g.. semiannually)

thereafter. Lr/er enryme changes generally occur in the first 3 monlhs ol treatment with

rasu'i'astatin Patients who develop increased transaminase levels should be monitored until

Ihe abnormalities have resolved. Should an increase m ALT or AST of >3 times ULN persist,

reduction of dose or wiina'av.-al ol rosuvastalm is recommended Rosuvaslatin should be

used w:th caution m pa'ienls who consume subslaniial quantilies of alcohol and/or have a

history of liver disease {see CLINICAL PHARMACOLOGY, Special Populaiions, Hepatic

Insufficiency). Active liver disease or unexplained persistent transaminase elevations are

contraindications to the use of rosirvastatin (see CONTRAINDICATIONS) Myopothy/RKabdomyolysis Rare cases ol rhabdomyolysis ivrth acute renal lailure secondary

to myoglobinuria have been reported nilh rosuvaslatin and with other drugs in this

class. Uncomp;:caieo myaigia has been reported m rosuvaslalin-lreaied patienis [see

ADVERSE REACTIONS). Creatine kinase (CK) elevations (>10times upper limit of normal)

occurred in 02% to Q,4% of patients taking rosuvastatin at doses up to 40 mg in clinical

studies. Treatment-related myopathy, defined as muscle aches or muscle weakness in

conjunclion vrth increases in CK values >10 times upper limit of normal, v/as reported m

up lo 0-1% ol patients taking rosuvastatin doses ol up lo 40 mg in clinical studies. In clin-

ical triafe, Ihe incidence ol myopathy and rliabdomyotysis increased at doses ol rosuva-

statin above ê recommended dosage range (5 lo 40 mg). In postmar1(eting experience,

effects on skeletal muscle, e.g. uncomplicated myalgia, myopathy and, rarely, rhabdomy-

olysis have been reported m patients trealed wilh HMG-CoA reductase inhibitors including

rosuvastatin As wilh olher HMG-CoA reductase inhibitors, reports ol rhabdomyolysis wfih

rosiwastatin are rare, but higher at Ihe highest marketed dose (40 mg). Faclors that may

predispose patients lo myopatliy with HMG-CoA reductase inhibilors include advanced age

{>K years), hypolfiyroidism, and renal insufficiency. Conseouently: t. Rosuvastatin

should be prescribed with cautran in patients wilh predisposing factors for myopathy, such

as. renal impairment (see DOSAGE AND ADMINISTRATION), advanced age, and inade-

qualely treated frypotftyroidism Z Palients should be advised to promptly report unex-

pbined muscle pain, tenderness, or weakness, particularly if accompanied by malaise or

fwer, Rosirvastatin iberapy should be discontinued if markedly elevated CK levels occur or

myopathy is diagnosed or suspected. 3. The 40 mg dose of rosuvaslatin is reserved only for

those palients vrtio have not acfiieved Iheir LDL-C goal utilizing Ihe 20 mg dose of rosuva-

stalm once daity (see DOSAGE AND ADMINISTRATION). 4. The risk ol myopalhy during

Ireatment with rosuvaslatin mjy be increased vflth concurrent admimslralion ol olher lipid-

lo-ivering therapies or cydosporine, (see CLINICAL PHARMACOLOGY, Drug Interactions,

PRECAUTIOfJS, Drug Interactions, and DOSAGE AND ADMINISTRATION), The benefit of

brfier alterations in lipid levels by the combined use ol rostivastatin with fibrates or

niacin sliojid be carefully weighed against Ihe potential risks of this combination.

Combination tfierapy wilh rosuvastatjn and gemlibrozil should generally be avoided.

ISe« DOSAGE AND ADMINISTRATIOH and PflECAUTIONS, Drug Interactions). 5. Tlie risk

of myopathy ilurinfi treatment with rotuvastatin may be increased in circumslances

liitft increae roiuvajtatin drug levels (tee CLINICAL PHARMACOLOGY. Special

PopslalJon], Race and Renal Insufficiency, and PRECAUTIONS. General)

: Rosnislatin Itierapy should alto be temporarily withheld In any patient with an

aole, unois condition tuggeitne ol myopathy or predisposing b the development ol

renal faikve tetondary lo rhabdomyalysts (e.g.. sepsis, hypotension, dehydration,

mjir sniffy, trajma. severe melabolic. endocrine, and electrolyte disorders, or

tmatiM utzures) PRECAUTIONS Generol Be'ore \'\:mmq therapy with

raswasWin, an attempi 'MM be rr.aOe to control hypercholeslerolemia with appropriate

(M and atercse, wti^nl recuclm 'n obese patients, and ireatment ol underlying medical

proWemi _($« INDKATIOMS m USAGE). Admmistralion ol rosuvastatin 20 mg to

padents wWi iwere rena) impairmenl (0^ <30 mL/min/1.73 m^) resulted in a 3-foltl

increase ii pfasma cononlraliofis ol roswastiiin compared v/ilh healthy volunteers (see

WARNINGS, Myopathy/Rhabdomyolysisand DOSAGE AND ADMINISTRATION). The resull

Ola taiQe phamiacofcMieliC study conducts) in Ihe US demonstrated an approximate 2-loid

ctovaEiofl In median exposure in Asian tubieds (having either Filipino, Chinese. Japanese.

Korea/t, Vietnamese or Asiart-lndian origin} compared with a Caurîan control group. This

inueau should be considered when making rosuvaslatin dosing decisions lor Asian

patienis. (See WARNIW^, Myopathy/Rhabdomyoiysis; CLINICAL PHARMACOLOGY

Special PopUatiOin, Rac«, and DOSAGE AMD ADMINISTRATIONlInformation for

Parienl>Raiefl(SthouldbeadviMdlorepor1(>rompl)yune):ptainedm/.<J-::i;i- - n.

iMse,or«eato>ess,parifcul3/lyllaccomi>anledbymalaii«orf?/er. V/huii/i'inr. >.

stMlriiiMh3n3taTiinurn2rKJmaone«umhydrnidecomt)frt;tonîi'.>-.'; [ii".i't^<ri'h'.iri

telalW3llo$t2fiOOTaflerroj(MSUlmadmiriiflra!/;n(>,^',_'. '.^ 'h;--!/;-' ,,/

Drvo H«actiom) laboratory Jtttt in the tc,i;/s:'^l' :I'kî I'i ,\ '.(.mi

(fpMicfcDDMi/e proieruria and rnvjoKopic nemaiuria were otn«''r-] '((i'.(«, -,

tttMiett6 vdtatt, predominant^/ in p3i«fits dcrKd above the '': "hm> i.: <r

afigeftt,WnHi)-Hoi(iwef,ttoriidi*iaw5imo(elfe<]uerrinp?i<^f[' unw./.iwt.uui

40iiig,wlMconiparedtolowefdOKiolr(>wvastiIinorc^ym[. ^'.r t::ii i -..jnttvâs

generjly tiani«« andw not SMOceUd wilh wortenirj r-:^^ '.ww.u îirMjgFi the

cMcaliigfliftanctdthafndinoisiKilcrwwn.adosered/.''.' '.ti'û': v '.w.&Mfor paiM on roiwaititin 40 mg Ihe^ wfth umtiUw-.i '/'.\-<-\ p'-'cnr.^

10 ii0ii»coatfaMHlef(diiillhGyct«porfne in cardiac tr:.f >w.i 'in

MeaHCnaMfmeanWCverelflerssedll-foldandM'.' < i v i<

lKa%^m«f).ThHeitwea$es are cornideted lobe'. 'i ' m iiÎ'mj-^

fpecol comiMfafion ii the doting ot rojwattabn lo iniîi:. ^hn(i mu>mm\

cyclosporine (see WARNINGS, Myopalhy/Rhabdomyolysis, and DOSAGE AND ADMINIS-

TRATION) Warfarin: Coadministration of rosuvastatin to palients on stable warfarin

therapy resulted in clinically significant rises in INR (>4, baseline 2-3). In patients taking

coumarin arlicoagulants and rosuvaslatin concomitantly, INR should be determined before

starting rosuvastatin and Ireguently enough during eariy Iherapy to ensure thai no signili-

cant alteralion of INR occurs. Once a stable INR time has been documented, INR can be

monrtored at the intervals usually recommended lor patienis on coumarin anticoagulants. II

Ihe dose of rosuvaslatin is changed, the same procedure should be repeated. Rosuvaslatin

Iherapy has not been associated with bleeding or with changes in INR in patients not laking

anticoagulants. Gemfibmzil: Coadministration of a single rosuvastatin dose to heahhy

volunteers on gemlibrozil (600 mg twice daily) resulted m a 2.2- and 1 .9-lold, respecliveiy,

increase in mean Cmax and mean AUC ol rosuvastatin [see DOSAGE AND ADMINISTRA-

TION). Endocrine Function Although clinical studies have shown that rosuvastatin

alone does not reduce basal plasma Cortisol concentration or impair adrenal reserve,

caution should be exercised if any HMG-CoA reductase inhibitor or other agent used to

lower choleslerol levels is administered concomilanlly v/ith drugs thai may decrease the

levels or activity of endogenous steroid hormones such as keloconazole, spironolactone,

and cimelidine. CNS Toxicily CNS vascular lesions, characterized by perivascular

hemorrhages, edema, and mononuclear cell infiltration of perivascular spaces, have been

observed in dogs treated with several other members of this drug class A chemically

similar drug in this class produced dose-dependent optic nerve degeneration (Wallenan

degeneration of relinogeniculate libers) in dogs, at a dose that produced plasma drug levels

about 30 times higher Ihan the mean drug level in humans taking Ihe highest recommended

dose. Edema, hemorrhage, and partial necrosis in the inlerslitium of Itie choroid plexus was

observed in a female dog sacrificed moribund at day 2'1 al 90 mg/kg/day by oral gavage

(systemic exposures 100 times the human exposure at -lO mg/day based on AUC compar-

isons) Corneal opacity was seen in dogs trealed lor 52 weeks at 6 mg/kg/day By oral

gavage (syslemic exposures 20 limes the human exposure al 40 mg/day based on AUC

comparisons). Cataracts were seen in dogs trealed for 12 weeks by oral gavage at

30 mg/kg/day (systemic exposures 60 limes Ihe human exposure at 40 mg/day based on

AUC comparisons). Retinal dysplasia and retinal loss were seen in dogs treated for <! weeks

SOSCRESTOR^rosuvastatin calcium

by oral gavage al 90 mg/kg/day (syslemic exposures 100 limes the human exposure at

40 mg/day based on AUC) Doses <30 mg/kg/day (systemic exposures <60 limes the

human exposure al 'lO mg/day based on AUC comparisons) following Ireatmem up lo one

year, did not reveal retinal Imdings Carcinogenesis, Mutagenesis, Impairment

of Ferriiily In a 104-v/eek carcinogenicity study in rals a! dose levels ol 2. 20, 60, or

80 mg/kg/day by oral gavage, Ihe incidence of uterine stromal polyps ms signilicanlly

increased in females at 80 mg/kg/day at systemic exposure 20 limes the human exposure

at 40 mg/day based on AUC. Increased incidence of polyps was not seen al lower doses. In

a 107-v/eek carcinogenicity study in mice given f 0, 60, 200 mg/kg/day by oral gavage, an

increased incidence ol hepatocellular adenoma/carcinoma was observed al 200 mg/kg/day

al syslemic exposures 20 times human exposure al 40 mg/day based on AUC. An increased

incidence of hepatocellular tumors was not seen al lower doses. Rosuvastatin was not

mutagenic or clastogenic with or without melabolic activation in the Ames test with

Salmonelis typhimurium and Escherichia coli, the mouse lymphoma assay, and the chro-

mosomal aberralion assay m Chinese hamsler lung cells Rosuvaslatin was negative in the

in vivo mouse micronucleus lest In rat fertility studies with oral gavage doses of 5, 15,

50 mg/kg/day, males were treated lor 9 weeks prior lo and throughout malmg and lemales

were trealed 2 weeks prior to mating and throughout mating until geslalion day 7. No

advene effect on fertility was observed at 50 mg/kfi/day (syslemic exposures up lo 1 times

human exposure at 40 mg/day based on AUC compansons). In testicles ol dogs treated

with rosuvastatin at 30 mg/kg/day lor one momh, spermatidic giant cells were seen.

Spermalidic giant cells were observed in monkeys afler 6-monlh Ireatment al 30 mgAg/day

in addition to vacuolation of seminiferous tubular epithelium. Exposures in the dog were 20

times and in the monkey fO times human exposure al 40 mg/day based on body surface

area comparisons. Similar findings have been seen with other drugs in this class.

Pregnancy Pregnancy CalsgoryXSee CONTRAINDICATIONS. Rosuvaslatin may cause

felal harm when adminislered lo a pregnant woman. Rosuvastalm is conlraindicaled in

women wtio are or may become pregnant. Safety in pregnant women has not been eslab-

lished. There are no adequate and v/eil-controlled studies of rosuvastatin in pregnant

women. Rosuvastatin crosses the placenta and is found in fetal tissue and amniotic lluid at

3% and 20%, respectively, ol Ihe maternal plasma concentration lollowmg a single

25 mg/kg oral gavage dose on gestation day 16 in rats. A higher lelal lissue dislnbulion

(25% maternal plasma concentration) v/as observed in rabMs aHer a singfe oral gavage

dose of 1 mgAg on gestation day !8. If this drug is adminislered to a woman wilh repro-

ductive potential, the palient should be apprised of the polemial hazard lo a fetus. In female

rats given oral gavage doses of 5. 15. 50 mg/kg/day rosuvastatin before mating and contin-

uing through day 7 postcoilus results in decreased fetal body weight (female pups) and

delayed ossilicalion al the high dose (syslemic exposures 10 times human exposure at

40 mg/day based on AUC comparisons), in pregnant rats given oral gavage doses of 2, 20.

50 mg/kg/day Irom geslatlon day 7 through lactation day 21 (weaning), decreased pup

survival occurred in groups given 50 mg/kg/day, systemic exposures >12 limes human

exposure at 40 mg/day based on body surface area comparisons. In pregnant rabbits given

oral gavage doses ol 0.3, 1 , 3 mgAg/day Irom gestalion day 6 lo laclalion day 18 (weaning),

exposures equivalent lo human exposure at 40 mg/day based on body surface area compar-

isons, decreased fetal viability and maternal mortality was observed. Rosuvaslatin was not

leratogenic in rals at £25 mg/kg/day or in rabbits <3 mg/kg/day (syslemic exposures

equivaleni to human exposure at 40 mg/day based on AUC or body surlace comparison,

respecliveiy). Nursing Mothers It is not known whether rosuvaslatin is excreted in

human milk Studies in laciaimg rals have demonslraled that rosuvastatin is secreted into

1.' :! '(ilk at levels 3 times higher than thai obtained in Ihe plasma following oral gavage

''IBecause many drugs are excreted in human milk and because of the potential lor

Hi'.ir, adverse reactions in nursing inlants Irom rosuvastatin, a decision should be made

v/hether lo discontinue nursing or admimslralion ol rosuvastarn laking mlo accoum the

importance ol ihe drug lo Ihe ladalmg woman Pediatric Use The safely and elleclive-

noss in pediatric patienis have nol been established Treatment experience wHh losuvaslalin

in a pediatric populalion is limited to 8 palients with homozygous FH. None ol those patients

was below 8 years ol age. Geriatric Use Of the 10.275 paliems in clinical studies with

rosuvaslalin. 3.159 (31%) were 65 years and older, and 698 (6 8%) were 75 years and

older The overall Irequency of adverse evems and types ol adverse events were similar in

palients above and below 65 years ol age. (See WARNINGS, Myopathy/Rhabdomyolysis

)

The efficacy ol rosiwasiatin In tlio geriatric population !^-G5 r^r. ol ;ion) was comparable

10 the ellicacy observed in tho non-elderly ADVERSE REACTIONS Rosuvaslatin Is

oenerall/ well tolerated Adverse readions have usu;;!!; mm: Luiniiansienl Inclmical

'ii'ii- . 'i\ 10.275 patienis, 3.7% were discontinued due lo adverr,(; expriiiences allnbulable

i'> r.'M/A'Min. The most Irequent adverse events thought lo be relaled lo rosuvastatin

•"": :v/;i|Qla, constipalion, asthenia, abdominal pain, and nausea. Clinical Adverse

Exporiencet Adverse experiences, regardieGS of causalily assessmonl, rcponod In ^2%

of palients m placebo-corlrolled clinical studies of rosuvaslatin are shown in Table 1;

discontinualions due lo adverse events in these studies ol up to 12 weeks duralion occurred

in 3% of palients on rosuvastatin and 5% on placebo.

Table 1. Adverse Events in Placebo-Conlrolled Studies

Rosirvaslalin Placebo

Adverse eveni N=744 N=382

Pharyngitis 9.0 7,6

Headaclie 5.5 5,0

Diarrtiea 3,1 2,9

Dyspepsia 3,4 3,1

Nausea 3,4 3.1

Myalgia 2,8 1,3

Asthena 2,7 2.6

Back pain 2,6 2.4

Flu syndrome 2,3 1,8

Urinary Iracl inlection 2,3 1.6

Rhinitis 2,2 2,1

SinusMs 20 1,8

In addition. Ihe following adverse events were reported, regardless of causality assessment.

in >1% of 10,275 patients trealed wilh rosuvastatin in clinical studies. The evenis in

Italics occurred in >2% ol these patients Body as a Whole: AbiJominal pain,

accidental injury, chest pain, inlecHon. pain, pelvic pain, and neck pain. Cardiovascular

System: Hypertension, angina pectoris, vasodilalalion, and palpitation. Digestive

System: Constipation, gastroenteritis, vomiting, llatufence. periodontal abscess, and

gastritis. Endocrine: Diabetes mellilus. Hemic and Lymphatic System: Anemia and ecchy-

mosis Metabolic and Nulrilional Disorders: Peripheral edema. Musculoskeletal

System: Arthritis arthralgia, and pathological Iraclure Nervous System: Dismess,

insomnia hypertonia, paresthesia, depression, anxiely, vertigo, and neuralgia Respiratory

System: Bronchitis, cough increased dyspnea, pneumonia, and asthma. Skin and

Appendages: RsshM pruritus. Laboratory Abnormalities: In Ihe rosuvastatin clinical trial

program, dipstick-posilive proteinuria and microscopic hematuna were observed among

rosuvastalin-trealed patienis, predammanlly in palients dosed above the recommended

dose range (i.e., 80 mg) However, this linding v/as more Irequent in palients taking rosuva-

statin 40 mg, when compared to lower doses of rosuvastatin or comparator statins, though

ft was generally transient and was not associated wilh worsening renal function. (See

PRECAUTIONS, Laboratory Tests) Other abnormal laboratory values reported were

elevated crealinine phosphokmase, transaminases, hyperglycemia, glutamyl transpepli-

dase, alkaline phosphatase, bilirubin, and Ihyroid lunction abnormalities Other adverse

events reported less frequently than 1% in the rosuvastatin clinical study program, regard-

less of causality assessment, included arrhythmia, hepatitis, hypersensitivity reactions

(i.e., lace edema, thrombocytopenia, leukopenia, vesiculobullous rash, urticaria, and

angioedema). kidney lailure, syncope, myaslhema, myositis, pancrealitis, photosensitvify

reaclion, myopathy, and rhabdomyolysis. Postmarketing Experience In addition lo

the evenis reported above, as with olher drugs in this class, tlie following event has been

reported during post-marketing experience with CRESTOR, regardless ol causality assess-

ment: very rare cases of laundice. OVERDOSAGE There is no specilic Ireatment in the

event of overdose. In the event ol overdose, the patient should be heated symplomaticaliy

and supportive measures inslituted as required Hemodialysis does nol signilicanlly

enhance clearance ol rosuvastalm. DOSAGE AND ADMINISTRATION The patiem

should be placed on a standard cholesterol-lowering diet belore receiving CRESTOR

and should continue on Ihis diet during treatment, CRESTOR can be adminislered as

a single dose at any lime of day. wilh of without food. Hypercholesterolemia

(Heterozygous Familial and Nonfomilial) and Mixed Dyslipidemto

[Fredrickson Type lla and lib) The dose range tor CRESTOR is 5 to 40 mg once

daily. Therapy with CRESTOR should be individualized according to goal ol therapy and

response. The usual recommended starting dose ol CRESTOR is 10 mg once daily.

However, inilialion of therapy with 5 mg once daily should he considered (or patients

requiring less aggressive LDL-C reductions, who have predisposing laclors lor myopathy,

and as noled below lor special populations such as patienis laking cyclosporine, Asian

palients, and patienis wilh severe renal msulliciency (see CLINICAL PHARMACOLOGY,

Race, and Renal Insufficiency, and Drug Inferactions. For patienis with marked hypercho-

lesterolemia (LDL-C > 1 90 nig/dl) and aggressive lipid targets, a 20-mg starting dose may

be considered. After initiation and/or upon titration of CRESTOR, lipid levels should be

analysed wilhin 2 to 4 weeks and dosage adjusted accordingly The 40-mg dose ol

CRESTOR is reserved only lor those patients who have nol achieved their LDL-C goal

utilizing the 20 mg doss ol CRESTOR once daily (see WARNINGS, Myopathy/

Rhabdamyolysis). liVhen initiating statin therapy or switching Irom another statin

therapy, the appropriate CRESTOR starting doss sfiould lirst be utilized, and only then

titrated according lo the patient's individualized goal ot therapy. Homo^gousFamilial Hypercholesterolemia The recommended starting dose ol CRESTOR is

20 mg once daily in palienis wilh homo^gous FH The maximum recommended daily dose

is 40 mg. CRESTOR should be used in these palients as an adjunct to olher lipid-lowering

treatments (e.g., LDL apheresis) or if such treatments are unavailable. Response lo therapy

should be estimated Irom pre-apheresis LDL-C levels Dosage in Asian Patients

Inilialion ol CRESTOR therapy wilh 5 mg once daily should be considered lor Asian

palients The potential lor increased syslemic exposures relative lo Caucasians is relevant

v/hen considering escalation ol dose in cases where hypercholeslerofemia is not adequately

controlled at doses ol 5, 10, or 20 mg once daily. (See WARNINGS, Myopathy/

Rhabdomyolysis. CLINICAL PHARMACOLOGY, Special Populaiions, Race, and PRECAU-

TIOMS, General) Dosage In Patients Taking Cyclosporine In patienis laking

cyclosporine, Iherapy should be limited to CRESTOR 5 mg once daily (see WARNINGS,

Myopalhy/Rhabdomyolysis, and PRECAUTIONS, Drug Interactions). Concomitant

Upid-Lowering Therapy The effcci of CRESTOR on LDL-C and tolal-C may be

enhanced v/hen used in combination wilh a bile acid binding resin. If CRESTOR is used in

combination wilh gemfibrozil, the dose ol CRESTOR should be limiled lo 10 mg once daily

(see WARNINGS, Myopalhy/Rhabdomyolysis, and PRECAUTIONS, Drug Inleraclions).

Dosage in Patients With Renal Insufficiency No modilication ol dosage is

necessary lor palients wilh mild to moderate renal insufliciency. For palienis with severe

renal impairment {Ql^, <30 mLymln/1.73 m^) not on hemodialysis, dosing ol CRESTOR

should be started al 5 mg once daily and nol lo exceed 10 mg once daily (see

PRECAUTIONS, General, and CLINICAL PHARMACOLOGY, Special Populations, Renal

Insufliciency).

Rjt only

flelerenees: 1. Prescribing Inlormalion for CRESTOR, AslraZeneca Pharmaceuticals LR

Wilmington, DE. 2. Data on file, DA-CRS-OI

CRESTOR is a registered trademark of the AslraZonoca group ol companfes

Pleaso visil our Web site at www.creslorcom

©AslraZonoca 2007 Licensed from SHIONOGI & CO,, LTD., Osaka. Japan

Manulaciured lor AslraZeneca Phaimaceulicals LP Wilminglon.DE 19850

By IPR Pharmaceuticals, Inc. Carolina, PR 00984

PCC 630101 30043-00

Rev 08/05 247665

AstraZeneca ir


SPONSORED BY

Salix#.Pharmaceuticals, Inc.

Advancing Treatment in Gastroenterology™

MAKERS OF

l^loviPrep CbsmolOVII(PEG-3350, Soim Sulfate, Sodium Chloride, Potassium Ctiloride,

Sodium Ascorbate and Ascorbic Acid for Oral Soioo)

.USP

and sodium ptiosphate dibasic aotiydraus, USP) Tablets

COLAZAl^ Xifaxan©balsalazide disodm (rifaximin) tablets 200 mg

www.Salix.com


We Impact Life

at Every Stage

At Abbott, we deliver

products you can count

on to provide superior

patient care — across

the spectrum of health.

Vascular

Diabetes Care

Metabolics

Spine

IVIolecular

Pain Care

Renal Care

Immunology

Anesthesia

Discovering new and better ways

to manage liealth has driven our

work for more than a century. Today,

our comprehensive line of products

spans the continuum of care -

from pharmaceutical therapies and

nutritional products to diagnostics

and surgical devices - addressing

important health needs from infancy

to the golden years, and in more

ways than even

We strive to earn your continued

trust by delivering high-quality, reliable

products backed by leading-edge

science and expertise across a range

of health care specialties. We deliver

on our promises by focusing on what

matters most: innovative care and

a desire to make a meaningful

difference in all that we do.

Visit us at abbott.com

Anti-lnfectives

Neuroscience

Virology

a

Cardiovascular

Nutrition

Oncology

AbbottA Promise for Life

Tulatie University |185

The Perfect Combination

4M^

^'e^

CURREiVT OPPORTUNITIES:

FamiK Practice

Internal Medicine

General Surgery

Neurosurger}'

Urology

Interventional Cardiology

ditional values. High-tech medicine. You'll find them

both in Springfield, Ohio. You can choose a suburban or

rural lilestyle, just right for your family. And just a short

drive from Colimibus and Dayton.

At Conmiunity Mercy Health Partners, health care is

state-of-the-art . . . deUvered with compa-ssion. Part of one

of the nation's largest not-for-profit health systems, we

offer cardiac surgery, cancer care in our regional cancer

center, obstetrics, pediatrics, and state-of-the-art diagnostic

services.

We offer rewarding practice opportimities. where you

can put your values and your skills to work.

Send CV or call David Andrick,

Director of Physician Recruitment, 937-328-8037

Community Mercy Health Partners

1 South Limestone St.

Suite 600

P.O. Box 688

Springfield, OH 4,5501

E-mail: [email protected]

^\g^

% CommunityMercyHealth Partners


CLEAN

t.OFMETAIRIE.J

MEAN

ATTENTION:

OF METAIRIE

885-3000 ' 3100 LIMT. STREETWWW.CADII.UCOFMKTAIRIR.COM

Family Practice and

Internal Medicine ResiderTEs

Exciting opportunities for

Primary Care Physicians:

In an effort to meet the healthcare needs of the

metropolitan New Orleans area, EJGH is expanding

its network of primary care physicians as the

community continues to rebuild.

This is an opportunity to be involved in the evolution

of healthcare delivery as the region continues to

re-establish its healthcare infrastructure.

Emailyour resume to

:

[email protected]

EastJefferson General Hospital

BEYOTND THE CUTTIMQ EDGf..

WWW.EJGH.org


Quest DiagnosticsNationally Recognized,

Locally Committed'

As the nation's leading provider of diagnostic testing, information and services. QuestDiagnostics offers the broadest range of innovative diagnostic services to meet the needsof you and your doctor.

So, when your doctor wants you to have a health related test, count on QuestDiagnostics. With patient service centers in Mississippi, Louisiana and Texas, finding alocation convenient to you will never be a problem.

For more information on our services, speak to your physician or visit us atwww.questdiagnostics.com .

Quest, Quest Diagnostics, the associated logo and all

associated Quest Diagnostics marks are the

trademarks of Quest Diagnostics. © 2004 Quest Diagnostics

Incorporated. All rights reserved.

(4W^ QuestDiasrnostics^ ®

Dialysis

Drug Delivery

Infusion Systems

Interventional

Irrigation/Urology

IV Sets Et Access Devices

Needlefree IV Systems

Nutrition ft Solutions

Pain Control

Pharmacy Admixture

Products £t Services

Vascular Access

Sharing Expertise.™

It's more than a philosophy.

It's a promise.

Sharing Expertise includes listening to the wisdom of

colleagues, customers, and clinicians, it's more than a

philosophy. It's our promise to the healthcare community

and ourselves to continuously seek knowledge.

To expand it. To apply it. To share it.

All to help improve and save lives.

This is Sharing Expertise.

This is B. Braun.

BIBRAUNSHARING EXPERTISE www.bbraunusa.com

Rx Only. a2006 B. Braun Medical Inc., Bethlehem PA. All rights reserved, UofFL 307 JH

188| Tulane UnivL^rsity

LEADING THE QUEST FOR HEALTH.More than 100 years ago, Cedars-Sinai was a small

hospital whose goal was to provide the finest quality

care to the Los Angeles community.

Today our reputation for excellence extends around

the globe. Our commitment to medical research and

innovation, combined with our passion for patient

care, has made us one of the most dynamic and

highly renowned medical centers in the world.

Medical education has been a core mission of

Cedars-Sinai since its inception. Our residency and

fellowship programs enable physicians to develop

their clinical expertise as well as participate in a wide

range of research activities.

At Cedars-Sinai, there are more than 600 research

projects underway, and we're making new discoveries

and putting them into practice every day.

Our goal is to stay at the forefront of medical

advancement. Only in this way can we maintain the

gold standard of excellence in healthcare for another

century to come.

FIND OUT MORE ABOUT OUR GRADUATE MEDICAL EDUCATIONWWW.CEDARS-SINAI.EDU/GME

Cedars-Sinai.


<(Roche>

We all dream ofdoing big things.

Solving importantproblems.

Making a difference. Improving lives.

Transforming these dreams

into reality requires ambition,

creativity, and a company like ours to

help put all the elements together.

We Innovate Healthcare

From Research

to Real Life

Roche is a leader in preventing, diagnosing and treating

disease, enhancing the quality of life for everyone.

We invest almost $5 billion a year in innovative research,

and our capabilities combine traditional biomedical

science with the latest advances in biotechnology,

genetics and genomics. Our investment in research has

led to the introductions of important new medicines for

osteoporosis and flu. And our current pipeline includes

potential advances for treating cancer, diabetes, arthritis

and hepatitis C.

Few companies possess the global strength in both

diagnostics and therapeutics that Roche enjoys.

By forging closer linl<s between diagnosis and

treatment, we're leading the way to a new dimension

in healthcare-individualized medicine. This approach

identifies the best treatment for a specific

individual.

And since we understand that every

individual is unique, we strive to ensure

a diverse workplace. Roche encourages

creativity and embraces differences in talent,

education, work style, lifestyle and culture.

Arthritis, cancer, diabetes, hepatitis, HIV/

AIDS, influenza, nervous system disorders

and osteoporosis - just some of the real life

issues Roche is focusing on and providing

solutions for.

Visit our global Web site atwww.roche.com

or our U.S. Web site at www.rocheusa.com.


Pediatrix Medical Group, the nation's largest physician group practice of maternal-fetal, newborn

and pediatric subspecialists, congratulates Tulane University Medical School's Class of 2007.

1 ediatrix offers physicians the best of both worlds: the chnical autonomy and atmosphere of a local private

practice coupled with the opportunities, administrative relief and clinical support that come from an affiliation with

a nationwide network. The company is unique not only because of its clinical and business expertise, but because

it has made a major commitment to education. Through our Professional Development Award program we have

extended that commitment to the support of neonatal, pediatric cardiology, pediatric critical care and maternal-

fetal medicine fellows. The program, which provides recipients up to $25,000 annually, allows interested and

qualified individuals to pursue these fellowship programs while relieving some financial burden.

For more information, visit www.pediatrix.com.

P€DIRTRi:i:. OBSTETRIC.MEDICAL GROUP MEDICAL GROUP

1301 Concord Terrace, Sunrise, Florida 33323 Tel: 800.243.3839 www.pediatrix.com


Notes

192| Tulane university

Tulane University

Rudolph Matas Medical Library

1430 Tulane Avenue (SL-86)

New Orleans, LA 70112-2699

DEMCO

11 llllllllllllll

OCT 2 1 2008

t-wave [yearbook] 2007

Documents